2-60881861-A-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The ENST00000394479.4(REL):c.10+11A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0775 in 1,487,866 control chromosomes in the GnomAD database, including 5,174 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.091 ( 702 hom., cov: 32)
Exomes 𝑓: 0.076 ( 4472 hom. )
Consequence
REL
ENST00000394479.4 intron
ENST00000394479.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0670
Genes affected
REL (HGNC:9954): (REL proto-oncogene, NF-kB subunit) This gene encodes a protein that belongs to the Rel homology domain/immunoglobulin-like fold, plexin, transcription factor (RHD/IPT) family. Members of this family regulate genes involved in apoptosis, inflammation, the immune response, and oncogenic processes. This proto-oncogene plays a role in the survival and proliferation of B lymphocytes. Mutation or amplification of this gene is associated with B-cell lymphomas, including Hodgkin's lymphoma. Single nucleotide polymorphisms in this gene are associated with susceptibility to ulcerative colitis and rheumatoid arthritis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 2-60881861-A-T is Benign according to our data. Variant chr2-60881861-A-T is described in ClinVar as [Benign]. Clinvar id is 1970920.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.113 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
REL | NM_001291746.2 | c.10+11A>T | intron_variant | ENST00000394479.4 | NP_001278675.1 | |||
REL | NM_002908.4 | c.10+11A>T | intron_variant | NP_002899.1 | ||||
REL | XM_017004627.3 | c.10+11A>T | intron_variant | XP_016860116.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
REL | ENST00000394479.4 | c.10+11A>T | intron_variant | 1 | NM_001291746.2 | ENSP00000377989 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0908 AC: 13808AN: 152024Hom.: 701 Cov.: 32
GnomAD3 genomes
AF:
AC:
13808
AN:
152024
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.107 AC: 9912AN: 92414Hom.: 589 AF XY: 0.111 AC XY: 5633AN XY: 50600
GnomAD3 exomes
AF:
AC:
9912
AN:
92414
Hom.:
AF XY:
AC XY:
5633
AN XY:
50600
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0760 AC: 101558AN: 1335724Hom.: 4472 Cov.: 30 AF XY: 0.0784 AC XY: 51619AN XY: 658328
GnomAD4 exome
AF:
AC:
101558
AN:
1335724
Hom.:
Cov.:
30
AF XY:
AC XY:
51619
AN XY:
658328
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0908 AC: 13815AN: 152142Hom.: 702 Cov.: 32 AF XY: 0.0936 AC XY: 6962AN XY: 74402
GnomAD4 genome
AF:
AC:
13815
AN:
152142
Hom.:
Cov.:
32
AF XY:
AC XY:
6962
AN XY:
74402
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
342
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at